Tci Gene Inc. · TPEX:6879

Tci Gene Inc. financial statements

Tci Gene Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue273.6M347.5M333.9M424.0M432.2M
Cost of revenue121.0M143.5M159.2M180.7M192.8M
Gross profit152.6M204.1M174.6M243.4M239.4M
Research and development33.7M34.1M45.6M62.3M59.5M
Selling, general and administrative99.8M114.2M123.0M89.9M66.4M
Operating income19.1M55.8M6.02M91.1M113.6M
Depreciation and amortization12.0M13.8M15.9M29.6M37.8M
EBITDA31.1M69.6M22.0M120.7M151.4M
Interest expense1.40M495.0K1.18M852.0K835.0K
Income before tax39.0M67.6M8.78M90.1M116.4M
Net income40.6M56.3M11.7M72.1M92.5M
Earnings per share, basic1.532.130.442.733.49

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents250.7M98.4M696.0M932.7M326.2M
Short-term investments581.0M738.5M203.6M5.00M4.00M
Receivables44.0M95.7M102.6M71.6M116.9M
Inventory18.8M43.9M54.8M57.0M31.2M
Current assets914.3M994.3M1.07B1.08B486.3M
Total assets1.01B1.10B1.17B1.16B560.3M
Accounts payable25.1M39.8M75.3M59.9M71.3M
Current liabilities98.6M101.3M155.5M143.2M169.4M
Total liabilities98.6M101.3M155.5M143.2M169.4M
Shareholders' equity890.5M974.7M986.5M1.01B380.2M
Shares outstanding26.5M26.5M26.5M26.5M26.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations151.3M57.0M17.8M110.4M119.2M
Capital spending-417.0K-2.66M-3.17M-15.3M-23.4M
Free cash flow150.9M54.3M14.7M95.1M95.8M
Dividends paid-52.9M-26.5M-52.9M-53.6M
Change in cash152.3M-597.6M-236.7M606.6M148.6M